Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival Outcomes

Low Dose ◽

Survival Outcomes ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Matched Sibling ◽

Reduced Risk

Haploidentical Transplant with Post-Transplant Cyclophosphamide Versus Matched-Sibling Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: We Must Continue to Discuss Whether One Is Better Than the Other or Just Decide According to the Availability of Graft Source?

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00296-7 ◽

2021 ◽

Vol 27 (3) ◽

pp. S237-S238

Author(s):

Gerardo López-Hernández ◽

Nideshda Ramírez-Uribe ◽

Haydee Del Pilar Salazar Rosales ◽

María De los Ángeles Del Campo Martínez ◽

Karla Maldonado-Silva ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Pediatric Patients ◽

The Other ◽

Hematopoietic Stem ◽

Matched Sibling ◽

Better Than

211: The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2006.12.215 ◽

2007 ◽

Vol 13 (2) ◽

pp. 77-78 ◽

Cited By ~ 1

Author(s):

B. Nasilowska-Adamska ◽

P. Rzepecki ◽

J. Manko ◽

A. Czyz ◽

M. Markiewicz ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Acute Graft

Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors

Bone Marrow Transplantation ◽

10.1038/s41409-020-0921-6 ◽

2020 ◽

Vol 55 (11) ◽

pp. 2147-2159 ◽

Cited By ~ 1

Author(s):

Juan Montoro ◽

José Luis Piñana ◽

Juan C. Hernández-Boluda ◽

Rafael Hernani ◽

Ignacio Lorenzo ◽

...

Keyword(s):

Stem Cell ◽

Mycophenolate Mofetil ◽

Cell Transplantation ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Unrelated Donors ◽

Matched Sibling

Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2016.06.013 ◽

2016 ◽

Vol 16 (9) ◽

pp. 527-535.e2 ◽

Cited By ~ 11

Author(s):

Seo Yeon Kim ◽

Hyewon Lee ◽

Mi-Soon Han ◽

Hyoeun Shim ◽

Hyeon-Seok Eom ◽

...

Keyword(s):

Stem Cell ◽

Natural Killer Cell ◽

Killer Cell ◽

Survival Outcomes ◽

Post Transplantation ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Acute Graft

283: The use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate to Prevent Graft-Versus-Host Disease following Unrelated Donor Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.12.293 ◽

2008 ◽

Vol 14 (2) ◽

pp. 105

Author(s):

R. Nakamura ◽

R. Rodriguez ◽

J. Palmer ◽

A. Nademanee ◽

J. Sun ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Low Dose ◽

Unrelated Donor ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Dose Methotrexate

Homozygous Status for HLA-E*0103 Confers Protection from Acute Graft-Versus-Host Disease and Transplant-Related Mortality in HLA-Matched Sibling Hematopoietic Stem Cell Transplantation

Transplantation Journal ◽

10.1097/01.tp.0000244598.92049.dd ◽

2006 ◽

Vol 82 (11) ◽

pp. 1436-1440 ◽

Cited By ~ 43

Author(s):

Ryad Tamouza ◽

Marc Busson ◽

Vanderson Rocha ◽

Catherine Fortier ◽

Yacine Haddad ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Matched Sibling ◽

Related Mortality ◽

Acute Graft

Haploidentical Hematopoietic Stem Cell Transplantation in Children with High Risk Hematologic Malignancies: Outcomes with Two Different Strategies for Graft-Versus-Host-Disease Prevention: Ex Vivo T-Cell Depletion and Post-Transplant Cyclophosphamide

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.879 ◽

2016 ◽

Vol 22 (3) ◽

pp. S370

Author(s):

Gustavo Dufort ◽

Luis Castillo ◽

Silvia Pisano ◽

Mariela Castiglioni ◽

Carolina Pages ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Disease Prevention ◽

Ex Vivo ◽

Hematopoietic Stem ◽

Graft Versus Host

Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood

Bone Marrow Transplantation ◽

10.1038/s41409-020-01047-2 ◽

2020 ◽

Author(s):

Xiaoqian Xu ◽

Jun Yang ◽

Yu Cai ◽

Su Li ◽

Jiahua Niu ◽

...

Keyword(s):

Stem Cell ◽

Cord Blood ◽

Low Dose ◽

Standard Dose ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Unrelated Cord Blood

REVISITING GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY DISEASE

10.26226/morressier.57bc1754d462b80290b4d4d2 ◽

2016 ◽

Author(s):

Bandar Al Saud

Keyword(s):

Stem Cell ◽

Severe Combined Immunodeficiency Disease

Severe Combined Immunodeficiency ◽

Combined Immunodeficiency ◽

Hematopoietic Stem ◽

Graft Versus Host ◽

Matched Sibling ◽

Immunodeficiency Disease ◽

CD34 Cell Dose and Chronic Graft-versus-Host Disease after Human Leukocyte Antigen-Matched Sibling Hematopoietic Stem Cell Transplantation

Leukemia & Lymphoma ◽

10.1080/1042819031000151103 ◽

2004 ◽

Vol 45 (1) ◽

pp. 27-34 ◽

Cited By ~ 8

Author(s):

MARCO MIELCAREK ◽

PAUL J MARTIN ◽

SHELLY HEIMFELD ◽

RAINER STORB ◽

BEVERLY TOROK-STORB

Keyword(s):

Stem Cell ◽

Human Leukocyte Antigen ◽

Human Leukocyte ◽

Hematopoietic Stem ◽

Leukocyte Antigen ◽

Graft Versus Host ◽

Matched Sibling